Sequoia Capital China and HighLight Capital have led a $16 million Series A round for Cullgen, a biotech company that develops treatments for cancer by targeting previously “undruggable” cellular proteins.
The biotech company was founded last year by Ying Luo, who trained and worked in the US before returning to China and establishing Shanghai Genomics in 2001. The company was subsequently acquired by Japan...
The Overseas Private Investment Corporation (OPIC), a development finance arm of the US government, will invest $185 million in India’s small to medium-sized enterprise sector.
500 Startups has teamed up with a unit of the United Nations to launch an impact-focused start-up accelerator in Indonesia.
Qiming Venture Partners has led a $37 million Series B round for Insilico Medicine, a Hong Kong-based drug development company that uses artificial intelligence (AI).
Texas County & District Retirement System (TCDRS) has committed up to $100 million to Baring Private Equity Asia’s seventh pan-regional fund.